Session 5A - OPIOID AGONIST TREATMENT
Tracks
.
Wednesday, November 15, 2023 |
8:45 AM - 10:00 AM |
Hall L |
Speaker
Professor Joanne Neale
Professor Of Addictions Qualitative Research
King's College London
Patients’ decisions to initiate long-acting injectable buprenorphine for opioid use disorder: qualitative study
8:45 AM - 9:00 AMBiography
Jo Neale is Professor of Addictions Qualitative Research based within the National Addiction Centre at King’s College London, UK. Jo's current research focuses on topics including novel treatments for opioid use disorder, opioid overdose, homelessness, patient reported outcome measures, and recovery focused interventions for substance use disorder.
Mr David Dwyer
Clinical Nurse Consultant
Agency Nurse
losing the plot, or sticking to the script: the experience of a registered nurse seeking guidelines on scope of practice and professional protection entering data onto opiate treatment therapy prescriptions.
9:00 AM - 9:05 AMBiography
A background from Med/Surg Nursing. Over 20 years of AOD experience, across 4 Australian States and Territories, covering capital Cities, regional, rural and remote, across all areas of AOD. always learning, always questioning, always open to new experiences. On the road and exploring Australia through work contrracts.
Dr Llewellyn Mills
Senior Research Associate
Specialty Of Addiction Medicine And South Eastern Sydney Local Health District
Australian Opioid Treatment Program staff perspectives regarding cannabis use by clients on Opioid Agonist Treatment: A Cross-Sectional Survey
9:05 AM - 9:20 AMBiography
Dr Llew Mills is a postdoctoral researcher with the Discipline of Addiction Medicine, University of Sydney and South Eastern Sydney Local Health District drug and alcohol treatment and research centre. He has worked on the biennial Cannabis as Medicine Surveys (CAMS) since 2018 and is the chief investigator of CAMS-2022.
Dr Gina La Hera Fuentes
Phd Students/Senior Lecturer
UNSW/UoN
Getting it over the line: Prescribing Opioid Agonist Treatment (OAT) in rural and regional primary care settings
9:20 AM - 9:35 AMBiography
Dr Gina La Hera Fuentes is a PhD student at the University of Newcastle and a Senior lecturer at the University of New South Wales.
She has expertise in the implementation and evaluation of projects and programs, aimed at delivering recommendations for the most efficient practices. Her professional focus centres on smoking cessation initiatives among First Peoples, alongside projects related to alcohol and other drugs.
Prof Michael Farrell
Director
UNSW
National trends in the Australian Opioid Agonist Treatment Program, 2013 to 2022
9:50 AM - 9:55 AMBiography
Professor Michael Farrell FRCP FRCPsych is the Director of NDARC. His extensive research interests include treatment evaluation and drug policy. He has an interest in drug dependence, comorbidity and drugs in the wider criminal justice system. Michael is a member of the WHO Expert Committee on Drug and Alcohol Dependence.
Chairperson
Anke van der Sterren
Deputy CEO
Alcohol Tobacco and Other Drug Association ACT
Technical Host
Room One
Touchpoint